Presentation TVT 2013 Optimal Femoral Access: Variations on How To Do It Presenter: William Gray June 12, 2013
Presentation Oral Anticoagulation (OAC) and Antiplatelets inA-fib Patients After MI and PCI Presenter: M. Lamberts June 12, 2013
Presentation TVT 2013 How Does the Heart Team Use Risk Scores and Other Parameters to Categorize Patients for TAVR in the European Union? Presenter: A. Pieter Kappetein June 12, 2013
Presentation TVT 2013 Pharmacotherapy Alternatives During and After TAVR: Is There an Optimal Regimen? Presenter: Corrado Tamburino June 12, 2013
Presentation TVT 2013 An Anticoagulated Patient with Severe Paravalvular Regurgitation and Ostial Left Main Disease Presenter: Peter Pollak June 12, 2013
Presentation TVT 2013 Are Dedicated Transcutaneous LV Apical Access Closure Technologies Important to "Revive" the TA-TAVR Procedure? Presenter: Joerg Kempfert June 12, 2013
Presentation TVT 2013 The Keystone Deflector Device: Technology and Early Clinical Experiences Presenter: Jeffrey Moses June 12, 2013